Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Paolo Gisondi and Denis Jullien.
Paolo Gisondi
Connection Strength
0.414
Denis Jullien
  1. Low incidence rate of respiratory and viral infections over 5 years of treatment with tildrakizumab in patients with moderate-to-severe psoriasis: pooled analysis from reSURFACE 1 and reSURFACE 2 phase 3 trials. J Eur Acad Dermatol Venereol. 2021 Nov; 35(11):e709-e711.
    View in: PubMed
    Score: 0.239
  2. Describing the burden of the COVID-19 pandemic in people with psoriasis: findings from a global cross-sectional study. J Eur Acad Dermatol Venereol. 2021 Oct; 35(10):e636-e640.
    View in: PubMed
    Score: 0.060
  3. Risk-mitigating behaviours in people with inflammatory skin and joint disease during the COVID-19 pandemic differ by treatment type: a cross-sectional patient survey. Br J Dermatol. 2021 07; 185(1):80-90.
    View in: PubMed
    Score: 0.058
  4. Factors associated with adverse COVID-19 outcomes in patients with psoriasis-insights from a global registry-based study. J Allergy Clin Immunol. 2021 01; 147(1):60-71.
    View in: PubMed
    Score: 0.057
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.